Susan L Greenspan
University of Pittsburgh
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
9
all conditions, ClinicalTrials.gov
NIH grants tied to them
11
3 more share only the name and are not shown
Trial papers
74
PubMed author-name match
Trials
Studies that name Susan L Greenspan as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:45 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT05058976 · Romosozumab Use to Build Skeletal IntegritySusan L. Greenspan · active not recruiting · Osteoporosis, Osteoporosis, Postmenopausal, Osteoporosis Fracture · principal investigator
- Ph4NCT02753283 · Preventing Osteoporosis Using DenosumabSusan L. Greenspan · completed · Osteoporosis, Postmenopausal, Osteoporosis, Osteoporotic Fractures · principal investigator
- Ph4NCT02589600 · Zoledronic Acid for Osteoporotic Fracture Prevention (ZEST II)Susan L. Greenspan · completed · Osteoporotic Fractures, Osteoporosis, Postmenopausal · principal investigator
- Ph4NCT01705587 · Fracture (FX) Improvement With Teriparatide: FiX-IT StudySusan L. Greenspan · completed · Osteoporosis, Atypical Femoral Fracture · principal investigator
- N/ANCT00558012 · Zoledronic Acid for Osteoporosis in the ElderlyUniversity of Pittsburgh · completed · Osteoporosis, Bone Loss, Fragility Fractures · principal investigator
- Ph4NCT00485953 · Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor TherapySusan L. Greenspan · completed · Bone Loss, Osteoporosis, Breast Cancer · principal investigator
- Ph3NCT00177619 · Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study)University of Pittsburgh · completed · Prostatic Neoplasms · principal investigator
- N/ANCT00118508 · The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)University of Pittsburgh · completed · Osteoporosis · principal investigator
- Ph3NCT00048841 · Prevention of Osteoporosis in Men With Prostate CancerNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Prostate Cancer, Osteoporosis, Hypogonadism · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Leadership & Administrative Core (LAC)P30AG024827 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2004 to 2024 · $398,503 awarded in 2024Same name and institution; not confirmed by an ID
- Preserving Geriatric Muscle with an Osteoporosis MedicationR01AG081359 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2023 to 2024 · $664,631 awarded in 2024Same name and institution; not confirmed by an ID
- Innovative Approach to Geriatric OsteoporosisR01AG066825 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2020 to 2023 · $551,841 awarded in 2023Grant number is on one of their registry trials
- Pitt Integrated Clinical and Geroscience Research Training ProgramT32AG021885 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2014 to 2022 · $365,797 awarded in 2022Same name and institution; not confirmed by an ID
- Long-Term Care Research NetworkK07AG052668 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2016 to 2020 · $87,775 awarded in 2020Same name and institution; not confirmed by an ID
- Sustaining Skeletal Health in Frail ElderlyR01AG052123 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2016 to 2020 · $920,744 awarded in 2020Grant number is on one of their registry trials
- Maintenance of Skeletal Integrity in Frail Elders-Phase 2R01AG050302 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2015 to 2019 · $576,995 awarded in 2019Grant number is on one of their registry trials
- Maintenance of Skeletal Integrity in Frail EldersR01AG028086 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2007 to 2013 · $91,483 awarded in 2013Grant number is on one of their registry trials
- Osteoporosis in Older Men and WomenK24DK062895 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2003 to 2012 · $179,857 awarded in 2012Same name and institution; not confirmed by an ID
- ONCE WKLY BISPHOSPHONATE PREVENTING OSTEOPOROSIS IN HYPOGONDAL MENM01RR000056 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2004 to 2005 · $92,935 awarded in 2005Same name and institution; not confirmed by an ID
- Prevention of Osteoporosis in Men with Prostate CancerR01DK061536 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2002 to 2005 · $269,156 awarded in 2005Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:45 UTC. The ranking covers the 200 most relevant of 74 PubMed records, and a shared surname and initials can bring in a namesake. All 74 on PubMed
- The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.N Engl J Med · 2003864 citationsRCR 23.1
- 458 citationsRCR 23.3
- One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis.N Engl J Med · 2005434 citationsRCR 12.6
- Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group.Aging (Milano) · 2000341 citationsRCR 10.7
- Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.Ann Intern Med · 2007332 citationsRCR 9.4
- Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: a randomized trial.Ann Intern Med · 2007230 citationsRCR 5.7
- Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy.Calcif Tissue Int · 2000225 citationsRCR 6.9
- Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW).J Bone Miner Res · 2014208 citationsRCR 8.6
- Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group.J Clin Endocrinol Metab · 2000203 citationsRCR 6.3
- A Randomized Trial of a Multifactorial Strategy to Prevent Serious Fall Injuries.N Engl J Med · 2020198 citationsRCR 13.2